Bertram Yuh, MD
Urology · Pasadena, CANPI 1306008164
Payments from drug & device makers
Across 284 payments — averaging $694.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$179K
- Virtual Incision Corporation$7K
- Vascular Technology, Inc.$4K
- Profound Medical Corp.$2K
- Palette Life Sciences, Inc.$1K
- Angiodynamics, Inc.$1K
- plus $3K from 14 others
What the payments were for
- Consulting fees$5,5863%
- Speaking & faculty fees$13,5507%
- Travel & lodging$34,19117%
- Food & beverage$10,3785%
- Education$133,55068%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 233 | $178,607 |
| Virtual Incision Corporation | 19 | $7,098 |
| Vascular Technology, Inc. | 2 | $4,320 |
| Profound Medical Corp. | 2 | $1,742 |
| Palette Life Sciences, Inc. | 3 | $1,391 |
| Angiodynamics, Inc. | 4 | $1,202 |
| Endo Pharmaceuticals Inc. | 1 | $500 |
| Verathon Inc. | 1 | $500 |
| Urogen Pharma, Inc. | 3 | $420 |
| Bard Peripheral Vascular, Inc. | 1 | $400 |
| Sanofi | 1 | $350 |
| Leica Microsystems Inc. | 1 | $176 |
| Janssen Scientific Affairs, LLC | 1 | $143 |
| Olympus America Inc. | 1 | $136 |
| Medtronic | 2 | $90 |
| Ferring Pharmaceuticals Inc. | 3 | $55 |
| Merck | 2 | $52 |
| Johnson & Johnson(2 entities) | 2 | $40 |
| 180 Medical, Inc. | 1 | $19 |
| Coloplast | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$171,046
- Mira!$6,775
- DA VINCI SP$5,824
- Tulsa-Pro$1,742
- Nanoknife$1,184
- NPD Clinical Study$500
- JELMYTO$420
- JEVTANA$350
- Erleada$143
- HD CAMERA HEAD$136
How this compares
$197,255 in reported general payments places this provider in the 90th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 13 | $5,611 |
| Tamsulosin Hcl | 97 | $1,170 |
| Finasteride | 39 | $525 |
| Solifenacin Succinate | 15 | $320 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $201 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 71 | $115 |
Paid to pharmacies, not to this prescriber.
Other urology in Pasadena
- Edward UchioOrange$21.1M
- Stephen FreedlandWest Hollywood$16.7M
- Alec KooTorrance$7.4M
- Karim ChamieLos Angeles$4.3M
- Ralph ClaymanOrange$3.9M
- Siamak DaneshmandLos Angeles$3.5M
- Arnold ChinLos Angeles$3.5M
- Roger LiLoma Linda$2.3M
- John KowalczykLos Angeles$1.8M
- Arie BelldegrunLos Angeles$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.